Skip to main content
Erschienen in: Acta Diabetologica 4/2017

09.01.2017 | Original Article

Absence of macrophage migration inhibitory factor reduces proliferative retinopathy in a mouse model

verfasst von: Jing Wang, Jihong Lin, Ulrike Kaiser, Paulus Wohlfart, Hans-Peter Hammes

Erschienen in: Acta Diabetologica | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Aims

Ischemia-induced neovascularization is the key feature of proliferative diabetic retinopathy. Macrophage migration inhibitory factor (MIF) is a pleiotropic proinflammatory and proangiogenic cytokine, and its levels are elevated in the vitreous of patients with proliferative diabetic retinopathy. In this study, we aimed at investigating the relative potential of MIF in the ischemia-induced retinal neovascularization.

Methods

Both WT and MIF-knockout mice were subjected to the retinopathy of prematurity (ROP) model. Intraretinal vessel regrowth was assessed by whole-mount immunofluorescence, and preretinal neovascularization was analyzed in retinal vertical sections after periodic acid-Schiff staining in the hypoxic stage of the ROP model. Gene expression of selected proangiogenic and proinflammatory factors at postnatal day 13 (p13) was measured by real-time PCR. Vascular endothelial growth factor (VEGF) expression, recruitment of endothelial progenitor cells (EPCs) and microglial activation were analyzed with immunofluorescence.

Results

MIF deficiency increased areas of vascular obliteration by 49%, reduced sprouting tips by 27% and inhibited preretinal angiogenesis by 35%. VEGF expression was reduced in Müller cells of MIF-knockout mice. MIF absence reduced gene expression of erythropoietin, tumor necrosis factor alpha and intercellular adhesion molecule-1 by 30, 70 and 50%, respectively, decreased the number of retinal EPCs by 37.5% and inhibited microglial activation in the hypoxic condition.

Conclusions

In conclusion, we found that MIF has proangiogenic and proinflammatory properties in retinal neovascularization. The proangiogenic role of MIF in ischemia-induced retinal neovascularization is associated with the expression of VEGF and erythropoietin, EPC recruitment and inflammation. Therefore, MIF has a potential role in the pathological angiogenesis of proliferative retinopathy.
Literatur
2.
Zurück zum Zitat Praidou A, Androudi S, Brazitikos P, Karakiulakis G, Papakonstantinou E, Dimitrakos S (2010) Angiogenic growth factors and their inhibitors in diabetic retinopathy. Curr Diabetes Rev 6(5):304–312CrossRefPubMed Praidou A, Androudi S, Brazitikos P, Karakiulakis G, Papakonstantinou E, Dimitrakos S (2010) Angiogenic growth factors and their inhibitors in diabetic retinopathy. Curr Diabetes Rev 6(5):304–312CrossRefPubMed
3.
Zurück zum Zitat Smith LE, Wesolowski E, McLellan A et al (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35(1):101–111PubMed Smith LE, Wesolowski E, McLellan A et al (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35(1):101–111PubMed
4.
Zurück zum Zitat Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT (1996) Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med 2(5):529–533CrossRefPubMed Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT (1996) Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med 2(5):529–533CrossRefPubMed
5.
Zurück zum Zitat Demircan N, Safran BG, Soylu M, Ozcan AA, Sizmaz S (2006) Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye 20(12):1366–1369. doi:10.1038/sj.eye.6702138 CrossRefPubMed Demircan N, Safran BG, Soylu M, Ozcan AA, Sizmaz S (2006) Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye 20(12):1366–1369. doi:10.​1038/​sj.​eye.​6702138 CrossRefPubMed
6.
Zurück zum Zitat Hernandez C, Burgos R, Canton A, Garcia-Arumi J, Segura RM, Simo R (2001) Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case–control study. Diabetes Care 24(3):516–521CrossRefPubMed Hernandez C, Burgos R, Canton A, Garcia-Arumi J, Segura RM, Simo R (2001) Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case–control study. Diabetes Care 24(3):516–521CrossRefPubMed
7.
Zurück zum Zitat Gardiner TA, Gibson DS, de Gooyer TE, de la Cruz VF, McDonald DM, Stitt AW (2005) Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am J Pathol 166(2):637–644CrossRefPubMedPubMedCentral Gardiner TA, Gibson DS, de Gooyer TE, de la Cruz VF, McDonald DM, Stitt AW (2005) Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am J Pathol 166(2):637–644CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Kociok N, Radetzky S, Krohne TU, Gavranic C, Joussen AM (2006) Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor–deficient mice. Invest Ophthalmol Vis Sci 47(11):5057–5065. doi:10.1167/iovs.06-0407 CrossRefPubMed Kociok N, Radetzky S, Krohne TU, Gavranic C, Joussen AM (2006) Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor–deficient mice. Invest Ophthalmol Vis Sci 47(11):5057–5065. doi:10.​1167/​iovs.​06-0407 CrossRefPubMed
11.
Zurück zum Zitat Mitamura Y, Takeuchi S, Matsuda A, Tagawa Y, Mizue Y, Nishihira J (2000) Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative diabetic retinopathy. Br J Ophthalmol 84(6):636–639CrossRefPubMedPubMedCentral Mitamura Y, Takeuchi S, Matsuda A, Tagawa Y, Mizue Y, Nishihira J (2000) Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative diabetic retinopathy. Br J Ophthalmol 84(6):636–639CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Asare Y, Schmitt M, Bernhagen J (2013) The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis. Thromb Haemost 109(3):391–398. doi:10.1160/TH12-11-0831 CrossRefPubMed Asare Y, Schmitt M, Bernhagen J (2013) The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis. Thromb Haemost 109(3):391–398. doi:10.​1160/​TH12-11-0831 CrossRefPubMed
14.
Zurück zum Zitat Bacher M, Meinhardt A, Lan HY et al (1998) MIF expression in the rat brain: implications for neuronal function. Mol Med 4(4):217–230PubMedPubMedCentral Bacher M, Meinhardt A, Lan HY et al (1998) MIF expression in the rat brain: implications for neuronal function. Mol Med 4(4):217–230PubMedPubMedCentral
15.
Zurück zum Zitat Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179(6):1895–1902CrossRefPubMed Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179(6):1895–1902CrossRefPubMed
19.
Zurück zum Zitat Toh ML, Aeberli D, Lacey D et al (2006) Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor. J Immunol 177(7):4818–4825CrossRefPubMed Toh ML, Aeberli D, Lacey D et al (2006) Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor. J Immunol 177(7):4818–4825CrossRefPubMed
21.
Zurück zum Zitat Bernhagen J, Krohn R, Lue H et al (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13(5):587–596. doi:10.1038/nm1567 CrossRefPubMed Bernhagen J, Krohn R, Lue H et al (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13(5):587–596. doi:10.​1038/​nm1567 CrossRefPubMed
24.
Zurück zum Zitat Koong AC, Denko NC, Hudson KM et al (2000) Candidate genes for the hypoxic tumor phenotype. Cancer Res 60(4):883–887PubMed Koong AC, Denko NC, Hudson KM et al (2000) Candidate genes for the hypoxic tumor phenotype. Cancer Res 60(4):883–887PubMed
27.
Zurück zum Zitat Chen J, Connor KM, Aderman CM, Willett KL, Aspegren OP, Smith LE (2009) Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Invest Ophthalmol Vis Sci 50(3):1329–1335. doi:10.1167/iovs.08-2521 CrossRefPubMed Chen J, Connor KM, Aderman CM, Willett KL, Aspegren OP, Smith LE (2009) Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Invest Ophthalmol Vis Sci 50(3):1329–1335. doi:10.​1167/​iovs.​08-2521 CrossRefPubMed
30.
Zurück zum Zitat O’Leary O, Reid E, McVicar C et al (2013) A novel Erythropoietin-derived peptide regulates Endothelial Progenitor Cell (EPC) mediated retinal vasorepair. ARVO Annual Meeting (2013); Seattle, United States, p 4619 O’Leary O, Reid E, McVicar C et al (2013) A novel Erythropoietin-derived peptide regulates Endothelial Progenitor Cell (EPC) mediated retinal vasorepair. ARVO Annual Meeting (2013); Seattle, United States, p 4619
31.
Zurück zum Zitat Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964–967CrossRefPubMed Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964–967CrossRefPubMed
37.
Zurück zum Zitat Wang J, Lin J, Schlotterer A et al (2014) CD74 indicates microglial activation in experimental diabetic retinopathy and exogenous methylglyoxal mimics the response in normoglycemic retina. Acta Diabetol 51(5):813–821. doi:10.1007/s00592-014-0616-9 CrossRefPubMed Wang J, Lin J, Schlotterer A et al (2014) CD74 indicates microglial activation in experimental diabetic retinopathy and exogenous methylglyoxal mimics the response in normoglycemic retina. Acta Diabetol 51(5):813–821. doi:10.​1007/​s00592-014-0616-9 CrossRefPubMed
Metadaten
Titel
Absence of macrophage migration inhibitory factor reduces proliferative retinopathy in a mouse model
verfasst von
Jing Wang
Jihong Lin
Ulrike Kaiser
Paulus Wohlfart
Hans-Peter Hammes
Publikationsdatum
09.01.2017
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 4/2017
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-016-0956-8

Weitere Artikel der Ausgabe 4/2017

Acta Diabetologica 4/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.